相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of the HCC-RESCUE score to predict hepatocellular carcinoma risk in Caucasian chronic hepatitis B patients under entecavir or tenofovir therapy
Fatih Guzelbulut et al.
JOURNAL OF VIRAL HEPATITIS (2021)
External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals
Jung Hyun Ji et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
Seung Up Kim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score
W. P. Brouwer et al.
JOURNAL OF VIRAL HEPATITIS (2017)
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival
Ahmedin Jemal et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma
Mar Riveiro-Barciela et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)
Norihiro Kokudo et al.
HEPATOLOGY RESEARCH (2015)
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends et al.
GUT (2015)
Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
Grace Lai-Hung Wong et al.
GASTROENTEROLOGY (2013)
Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies
Robert D. Mair et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
分享论文
